mopidamol has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellmann, K; Hutchinson, G; Lichtner, RB | 1 |
1 other study(ies) available for mopidamol and B16 Melanoma
| Article | Year |
|---|---|
The pyrimido-pyrimidine derivatives RA233 and RX-RA85 affect cell cycle distribution of two murine tumour cell lines.
Topics: Animals; Cell Cycle; Cell Line; Flow Cytometry; Lung Neoplasms; Melanoma, Experimental; Mice; Mopidamol; Phosphodiesterase Inhibitors; Pyrimidines; Tumor Cells, Cultured | 1989 |